Dr. Capasso is currently an Associate Professor in University of Salerno. Prof. Capasso from 1997 at today is a tutor of several graduation and Ph.D thesis. Prof. Capasso is member of Italian Society of Pharmacology, Italian Society of Neurosciences and International Narcotics Research Conference Group. The research of Prof. Anna Capasso are documented by about 500 publications (including articles in extenso, chapters of books and congress international communications). Professor Capasso is the winner of Young Participant Award (1992-1995), ECNP Fellowiship Award (1996), EOC Bursary (1997) etc .

Dr. Cho is currently a Professor in Seoul National University. He completed his Ph.D in Physiology & Cell Biology, The Ohio State University, Columbus, OH, USA. Dr. Cho has been a member of Asia Oceania Human Proteome Organization (AOHUPO), Korean Human Proteome Society and many more. The research of Dr. Cho is documented by 100 plus publications (including articles in international journals, domestic journals and chapters of books). His field of expertise include comparative medicine-based cancer biomarker development, proteogenomics study of cancer and cardiovascular disease and cardiovascular regeneration by stem cell engineering.

Dr. Jaw-Wen Chen has been to the cardiovascular research center of Stanford University in USA for post Doc research. His research work is focus on atherogenesis, vascular progenitor cells and angiogenesis, and genetic and clinical biomarkers of cardiovascular diseases. He is also the first vice president of Taiwan Society of Cardiology, the honor board of Taiwan Society of Lipids and Atherosclerosis, and the follow of American Heart Association (FAHA), European Society of Cardiology (FESC), and Asia-Pacific Society of Cardiology (FAPSC). Till August 2016, he has published more than 280 scientific papers in international SCI journals.

Dr. M. Akhter Hossain completed his BSc and MSc from Department of Biochemistry, University of Dhaka, PhD in 2001 from Tokyo Institute of Technology, Japan, and undertook postdoctoral studies in Joseph Fourier University, France. He is currently the head of “Insulin Peptides Laboratory” since 2012 at the Florey Institute of Neuroscience and Mental Health, University of Melbourne, Australia. He was awarded a JSPS early career postdoctoral fellowship (Japan Govt) in 2003. He has published more than 114 papers in key international journals including JACS, Angewandte Chemie and others. His group is interested in developing novel chemical methods for preparing therapeutic insulin and insulin-like peptide-based drug.

Shengshui Hu works as a Professor at Wuhan University, China. From 1988 to 1990, he had been a guest research fellow in Chalmers University, Sweden. In 1995, he worked as a senior visiting scholar in Universitá Degli Studi di Firenze, Italy. During 1995–1998, he was a visiting research fellow in Case Western Reserve University, USA. His research interest includes biosensors, chemical sensors, bioelectrochemistry, nanoelectrochemistry, bioelectroanalysis and direct electron transfer of proteins, as well as biochemically modified electrodes based on nanocomposite materials. He has authored more than 200 research papers in peer reviewed journals.

Prof. Sunil K. Khare received his PhD from IIT Delhi, carried out Postdoctoral Research at National Food Research Institute, Tsukuba, Japan and has been DBT visiting scientist at Northern Regional Research Laboratory, Illinois USA. He has been working in the area of solvent-tolerant and halophilic class of extremophiles and their enzymes; especially understanding structural and molecular basis of their stability. His current noteworthy contributions have been in differential proteomics of solvent-tolerant and halophilic class of extremophiles and deciphering nanotoxicity mechanisms in plant and microbial systems. The work has led to 125 publications with high impact, 2 patents, 12 book chapters to his credit.

Dr Kim obtained a doctorate (Ph.D) in Biochemistry from The University of Tokyo. Dr. Kim, currently, is a professor in Sungkyunkwan University, Korea. Also he is an adjunct professor in Samsung Advanced Institute of Health Science and Technology. His works cover the Cancer biology, Angiogenesis, Leukemia, Gene expression and transcriptional regulation, Glycosyltransferase, Tumor associated carbohydrate antigen, Carbohydrate Vaccines, Cell cycle, apoptosis, carcinogenesis, oncogenic transformation, growth factor-receptor interaction; cell differentiation; carbohydrate antigen; cell adhesion and angiogenesis; signal transduction.

He has published more than 367 scientific publications and 9 books and is a holder of 27 Korea, US, EU and Japan patents.

Chiara Riganti graduated in Medicine at University of Torino, Italy in 2002. She is tenured associate professor of biochemistry at the University of Torino, Italy. She awarded the SIB (Italian Society of Biochemistry) medal for young investigators in 2005 and the AICC/ECTS (Italian Association for Cells Culture/Italian Branch of the European Tissue Culture Society) award for senior investigators in 2011. Her research is focused on the molecular basis of multidrug resistance in human cancer cells and on the molecular basis of immunoresistance and immunotolerance in human tumors. She co-authored more than 100 papers in peer-review journals and filed 2 patents.

Professor Stone is a graduate of the University of London and the University of Aberdeen, and is currently a Professor of Pharmacology at the Unviersity of Glasgow. At present, he combines his teaching activities with his role as co-cirector of PharmaLinks, a research cooperative between the Universities of Glasgow and Strathclyde, and as a Consultant Research Pharmacologist to the Royal Hospital for Neuro-disability. Professor Stone has published over 360 full research papers, over 200 proceedings abstracts, and has authored or edited 13 books. He is a member of several international societies and associations, and is a fellow of the Royal Society of Medicine and the British Pharmacological Society.

Dr. Dianping Tang obtained his Ph.D. (2008) in Analytical Chemistry from Southwest University, China. Since Sep 2009, he is Professor of Analytical Chemistry at Institute of Nanomedicine and Nanobiosensing (Leader), Department of Chemistry, Fuzhou University, China. His research interests involve Clinical/enviromental immunoassays, Biological and chemical microsensors, Synthsis and application of advanced functional nanomaterials, and Fabrication of microfluidic device. In 2013, he was bestowed with the award of one of the 100 Most Influential People in The Analytical Scientist. Dr. Tang, as an author/co-author, has been involved in the publication of more than 235 articles in various international journals, with total citations of around 7,100.

Kwang-Hyun Baek is a full professor of Department of Biomedical Science at CHA University in Korea. He received his Ph.D. at Iowa State University in 1995 and worked as a postdoctoral research fellow in the department of Pediatric Oncology at Dana-Farber Cancer Institute, Harvard Medical School. Current research and clinical interests are in the molecular genetics of ubiquitination and deubiquitination systems relevant to various cancers. He first coined terms ubiquitomics and deubiquitomics in the field of the ubiquitin-proteasome system. In addition, he is also interested in genomics and proteomics during stem cell proliferation, differentiation, and reprogramming.

The scientific activity of Dr Monti is focused on structural and functional characterization of proteins and bioactive peptides. Studies were initially focused on the impact of food processing on human health. Subsequently, Dr Monti moved to production and biochemical characterization of proteins involved in biomedical pathways. An important part of the research is focused on the study of ubiquitous metallo-enzyme Carbonic Anhydrases. In humans, abnormal levels or activities of CAs are associated with different human pathologies such as glaucoma, neurological disorders and cancer. Dr. Monti combines molecular biology, biochemical and biophysical techniques into her research.

Professor Wong is currently a Chair Professor of the Division of Life Science at The Hong Kong University of Science and Technology. He is also the Director of Biotechnology Research Institute and the Co-Director of Molecular Neuroscience Center. He graduated from the Department of Pharmacology at the University of London, United Kingdom, and received his PhD degree from the MRC Molecular Neurobiology Unit and Department of Pharmacology at the University of Cambridge. As a highly accomplished researcher, Prof Wong has published over 210 scientific papers in leading journals and holds 6 patents.

Prof Suleyman Aydin has received his PhD in Illinois Institute of Technology during the period of 1999. Currently, he is working at Medical School as Professor of Medical Biohemistry in Firat University. He has authored more than 175 research articles/books. He is currently also serving as scientific Reviewer for various academic journals He is a member of Organization Committee Members, Council Members,, The American Turkish Society, Turkish Biochemical Society and The Endocrine Society). He has honoured as Certificate in Laboratory Animal Science, Good Clinical Practice (GCP) and statistics, Certificate in Clinical Trial, Trainer’s Training Certificate and Pedagogical Formation Training Certificate.

Federica Compostella graduated in Chemistry. She is assistant professor in biochemistry at the University of Milano, where she is currently in charge of the chemistry and introductory biochemistry courses at the International Medical School. Her research focuses on the synthesis of compounds with biological applications. In this context she collaborates with a number of national and international laboratories (Ottawa Hospital Research Institute, Eijkman Institute for Molecular Biology…). Her main research topics are on the synthesis of bacterial capsular polysaccharide fragments for the development of synthetic vaccines, and of glycolipids related to ceramides and glycerol as immunomodulators and enzyme inhibitors.

Dr. Abdel Moneim is associate professor, Faculty of Science, Helwan University. He has nearly 15 years of experience in the research, discovery and development of medications based on natural products aimed to treat different diseases included diabetes, neurological disorders and environmental toxicities. During his career at Helwan University, Dr. Abdel Moneim holds a Ph.D. in Physiology. Notably, Dr. Abdel Moneim has authored more than 70 manuscripts and he teaches physiology and pharmacology as a faculty member at Helwan University.

Dr. Ali is head of Genetic Engineering and Biotechnology Division, National Research Centre, Egypt. Dr. Ali holds Ph. D. from Biochemistry Department, Faculty of Science, Ain Shams University, Egypt. His research interest is in the area of cancer treating and cancer chemoprevention (including nanomedicine, photodynamic therapy and photothermal therapy) using natural, semi-natural and synthetic agents. Dr. Ali is supervisor of many theses, he published > 105 international and national publications, 7 international books, he is PI of several national and international projects. Dr. Ali is member of editorial boards and reviewer in > 133 international journals and in many national and international societies.

Dr. Amato is currently PI in the Molecular Oncology Lab III of the DPT of Health Sciences at the University of Magna Graecia in Catanzaro. Doctor, radiotherapy specialist, has obtained the PhD in Molecular Oncology, Experimental Immunology and Development of Innovative Therapies. His primary field of interest is the study of the kinases involved in human tumorogenesis, the study of new pharmacological targets, up to the radiobiology. Important his seminal works that have established an oncogenic role for the kinase SGK1 and its involvement in mechanisms of chemo-radio resistance and in cellular epigenomic reorganization through the control of nuclear transport.

Maria Luisa Balestrieri is currently an Associate Professor in Biochemistry at the University of Campania “Luigi Vanvitelli”. She received her Ph.D at the University of Naples "Federico II" and worked as Researcher Assistant at the Basic and Applied Research Unit, Oak Ridge Associated Universities (ORAU), Tennessee, USA. She has authored more than 102 research article/books. She is Member of the Italian Society of Biochemistry (SIB). Her research interest includes inflammation, angiogenesis, apoptosis, atherosclerosis, cell senescence, vascular biology, endothelial progenitor cells, endothelial dysfunction, sirtuins, natural products, antioxidants, cell cycle, cancer-related biochemical pathways, signal transduction.

Dr. B. D. Banerjee is working as a Professor of Biochemistry, Department of Biochemistry, University College of Medical Sciences and G.T.B. Hospital, University of DELHI, India since 28th November 2000. He has also served as the Head of the Department of Medical Biochemistry, University of Delhi from January 2009 - January 2012. He obtained his B.Sc (Hons), M.Sc, M. Phil and Ph.D (Biochemistry) degree from the prestigious Central University of central Govt. of India.

Dr. Belo is assistant professor at Faculty of Pharmacy of the University of Porto. He also performs medical work in hemodialysis clinics. He has nearly 20 years of experience in research, currently being investigator at the Research Unit on Applied Molecular Biosciences (UCIBIO), REQUIMTE, Porto, Portugal. The cradle of his research has spanned several areas mainly related to clinical medicine that have in common the existence of inflammatory and/or oxidative stress in their pathophysiological mechanisms. All these areas were already covered with the allocation of funding for research projects by institutions of recognized merit.

Dr. Carugo obtained a doctoral degree in Chemistry at the University of Pavia in 1985. After research experiences at the European Molecular Biology Laboratory (Heidelberg, Germany) and at the International Centre for Genetic Engineering and Biotechnology (Trieste, Italy), he presently teaches Chemistry and Structural Bioinformatics at the University of Pavia, Italy and at the University of Vienna, Austria. He also published more than 150 scientific publications.

Alessandro Di Cerbo obtained the bachelor degree in Medical and Pharmaceutical Biotechnologies at University Vite-salute San Raffaele (Milan, Italy) in 2005. In 2007 achieved the Master degree in Medical Biotechnologies at University of Modena (Italy) and in 2011 obtained the title of PhD in Nanoscience and Nanotechnology at the same University. In 2016 he got the postgraduate Diploma in Clinical Biochemistry at the G.d'Annunzio University (Chieti, Italy). Recently he devoted his interests and researches to the study of the oxytetracycline (OTC) and its health-related risks in the food processing chain; the understanding of the mutual biological interactions between nutraceuticals and living systems; the identification of the response of biological systems upon interaction with biomaterials. He is author and co-author of more than 50 articles in peer-reviewed international journals and attended several national and international conferences

Dr Tai-an Chiang is a Dean, Director, College of Medicine and Life Science, and Professor of Department of Medical Laboratory Science and Biotechnology. Chung Hwa University of Medical Technology (CUMT), Tainan County, Taiwan (R.O.C.). He has received PhD in Graduate Institute of Medicine, Kaohsiung Medical University in Kaohsiung Taiwan (R.O.C.) in 1997 He has completed his Master of Science in Kaohsiung Medical Institute (1992), his Bachelor of Medical Technology from Kaohsiung Medical Institute, School of Medical Technology in Taiwan (1986). Dr Chiang’s research is focused on cancer genetics, cancer biostatistics, transcriptional regulation, chemoprevention study via cell and animal models. He is serving as international journal reviewer for a number of reputed journals such as Food and Chemical Toxicology, Journal of Agricultural and Food Chemistry, International Journal of Experimental Pathology et al , and has more than 50 publications.

Dr. Chen is research microbiologist and principal investigator at National Center for Toxicological Research (NCTR), US Food and Drug Administration (FDA). Dr. Chen holds a Ph.D. in microbiology from Shandong University. Dr. Chen has authored more than 50 scientific publications and 7 patents. Dr. Chen received FDA Commissioner’s Special Citation Award, NCTR Director’s Award, and NCTR Scientific Achievement Award.

P. Ciuffreda is Associate Professor in Biochemistry of Department of Biomedical and Clinical Sciences “L. Sacco” University of Milan (Italy). She has received Ph.D. in Biochemistry and Board certified in Pharmacology. P. Ciuffreda research interests include synthesis, quantification and NMR characterization of bioactive compounds such as steroids, glycosides, nucleotides, and applications of biocatalysis to the synthesis of compounds of biopharmaceutical interest. Ongoing projects regard both the synthesis and biological characterization of FAAH, MAGL, and NAAA inhibitors, and the quantification in biological matrices of endocannabinoids and N-acylethanolamides. Pierangela Ciuffreda is the author of 115 publications in peer-reviewed scientific journals and of many communications and at national and international symposia.

Dr. Ciulla is a Senior researcher with main focus on cardiovascular remodeling in organ damage. He has developed and validated versus biopsy a new technique for the quantitative analysis of ultrasonic images for the non-invasive assessment of myocardial fibrosis and the assessment of carotid plaques. The analysis technique has also been applied in other areas including the morphological analysis of cell cultures. He has coordinated a research project on stem cells in a model of experimental myocardial infarction. Dr Ciulla has authored 117 publications that have been cited a total of 857 times.

Alfonso Clemente is a researcher of the Spanish National Research Council (CSIC) and is currently President of the Spanish Legume Association and Scientific Committee Member of the Spanish Society of Probiotics and Prebiotics. Over the last 20 years, his scientific interest has been mainly focused on the nutritional and health beneficial effects of bioactive peptides and oligosaccharides in gut health. He has worked in several relevant institutions of UK, including John Innes Centre, Institute of Food Research and Sainsbury Laboratory. Dr. Clemente has authored more than 90 peer-reviewed manuscripts.

Dr. Timothy Cunningham is Professor of Neurobiology and Anatomy at Drexel University College of Medicine. He has conducted research related to cell death, cellular repair, and application of peptide therapeutics for over 40 years, including the discovery and isolation of proteins and peptide fragments that promote cell survival. Dr. Cunningham was a regular member of Neurology B2 Advisory Panel for the National Institutes of Health currently serves as scientific consultant for Promet Therapeutics.

Dr. D. K. Dhawan is presently working as a Professor in the department of Biophysics and also worked as chairman department of Biophysics, Coordinator of Centre for Nuclear Medicine as well as Centre for Medical Physics at Panjab University, Chandigarh, India. Professor Dhawan completed his M.Sc. (Honors) from Panjab University in 1978 and Ph.D. from PGIMER, Chandigarh, in 1984. His research areas are radiation medicine, diabetes, neurodegeneration and cancer and. He has published 181 research articles. Prof. Dhawan has supervised 33 Ph.D. and 42 M.Sc. theses of students. He is a Fellow of Indian College of Nuclear Medicine and Indian Association of Biomedical Scientists.

Dr Alka Dwevedi has completed her PhD in 2009 from Banaras Hindu University, India followed by postdoctoral studies from University of Western Ontario, Canada and Indian Agricultural Research Institute, India. She has joined UNESCO-Regional Centre for Biotechnology, India as young investigator in 2011. She is adjunct faculty in various colleges of University of Delhi. She is presently associated with Delhi Technological University. She has published 30 articles in peer review journals. She has published 7 book chapters and 3 books with renowned publishers. Further, she is a life member of Indian Biophysical Society and also a member of American Chemical Society.

Gabriella Fiorentino is Professor at the Department of Biology of the University of Naples Federico II. Her research interests include the study of the molecular mechanisms of adaptation of microorganisms to harsh conditions and the development of biosensors for environmental monitoring of aromatic and heavy metal compounds. She is member of the Italian Society of Biochemistry and participates in funded projects within the EU.

Dr. Giulio Gabbiani has obtained a PhD degree at the University of Montreal (Canada). He is an Emeritus Professor of the University of Geneva (Switzerland). His scientific interests include soft tissue remodeling during development and pathological situations and arterial smooth muscle adaptation during development and diseases.

Dr. Gabbiani has been Secretary and President of the European Cytoskeleton Forum, Secretary and Chairman of the European Vascular Biology Association, Secretary of the European Tissue Repair Society. He has received several distinctions including a degree of Doctor Honoris Causa from the University of Gothenburg (Sweden) and from the University of Limoges (France).

Dr. Gentile is PhD Biochemistry at the Dipartimento di Medicina Clinica e Chirurgia, Università di Napoli Federico II. His research interests include Dyslipidemias, Lipoproteins and Epidemiological Studies (Progetto Atena, Progetto Diana). He is member of SISA (Italian Society for the Study of Atherosclerosis). He has published 41 full papers.

Laurea cum laude in Biological Science in 1995. PhD in Cellular Biology (Cellular and Developmental Biology) in 2003. From May 2011 confirmed researcher in the Faculty of Sciences, University of Palermo, Italy

Research activity has been mainly focused on stress response in sea urchin embryos (P.lividus) and in mouse stem cells. The recent research regards cell communication mediated by membrane vesicles, and their possible involvement in neurodegenerative disease ( i.e . multiple sclerosis).

Dr. Illana Gozes is a Professor of Clinical Biochemistry, at Tel Aviv University. Dr Gozes received her PhD from Weizmann Institute of Science in Israel and was a postdoctoral fellow at Massachusetts Institute of Technology (MIT), USA. Prof. Gozes has published ~300 papers. There are >100 results (encompassing >15 patent families) found in the worldwide database for Gozes as an inventor. Professor Gozes has won the Tel Aviv University Vice President Award for Innovative Research, Olson Prize for the most meritorious original research article in Peptides, the Julodan Prize, the Teva Founders Prize, the Neufeld Research Award, the Humboldt Research Award, and the Landau Prize for Life Achievements.

Prof. Roberta Granese (female) received her degree in Medicine from University of Messina, Italy, in 1998 (110/110 cum-laude). She is a specialized in Gynecology and Obstetrics at the University of Messina, Italy, in 2003 (50/50 cum-laude) and received her PhD degree in “Therapeutic alternative to the hormonal therapy in the treatment of climacteric syndrome” from University of Messina, Italy, in 2008. Currently, she is a Senior Lecturer in the U.O.C. of Obstetrics and Gynaecology in Department of Human Pathology in Adulthood and Childhood “G. Barresi” at the University Hospital of Messina, Italy. She is currently lecturing various Master, PhD and Degree Course in the University of Messina. She is the author of two Chapter in two International Ultrasound in Obstetrics and Gynecology Books. Her other publications includes: 51 Abstracts published in the proceedings of congresses or in supplements of National and International Journals, 81 articles in National and International Journals, and 60 articles on various web-sites ( e.g ., www.ilfeto.it and www.thefetus.net http://www.thefetus.net.

Dr. Gregan obtained PhD in genetics from the University of Vienna and worked as a postdoc at the University of Oxford and the Research Institute of Molecular Pathology in Vienna. He started his first laboratory at the Max F. Perutz Laboratories in Vienna and since 2013 he works as an associate professor at the Comenius University in Bratislava.

Prof. Dr. Imad Hadi Hameed obtained my PhD in Biotechnology from University of Babylon in 2015, and subsequently worked at Babylon University, College of Nursing, Iraq. My research activities are mainly on Biotechnologies, medicinal plants, anti-bacterial and anti-fungal activities. I have authored more than 80 papers in scientific journals and 2 patents. I am the editor board member of Scientific Reports in the field of biotechnology.

Prof. Heese received an MSc in Chemistry (Germany) and a PhD in Biochemistry (Switzerland). From 1998 to 2003, Prof. Heese was the Research Head in the Division of Molecular Neurobiology, Brain Function Research Institute. Prof. Heese worked as an Assistant Professor in Nanyang Technological University from 2004 to 2010. Currently Prof. Heese holds the position of Professor in Hanyang University, Graduate School of Biomedical Science & Engineering. His research interests include Cognitive Neuroscience, Neurodegenerative Diseases, Neuro-Immunology, Aging, and Cancer.

The scientific activity of Dr. Hegardt is focused on Reversion of the obesity and of diabetes type 2 by injection of Adeno Associated Virus having constructs of malonyl-CoA insensitive cDNAs of CPT 1, Hypothalamic regulation of food intake by overexpression of CPT 1A, Hypothalamic regulation of food intake by pharmacologic action of paraconic acid derivatives, Reversion of insulin resistance in clonal muscle cells by the expression of Carnitine Palmitoyltransferase 1A, Molecular análisis of mutations producing hereditary diseases in ketogenesis (mitochondrial HMG-CoA synthase and HMG-CoA lyase), Reversion of solid cancer tumours by the (-)-C75 enantiomer and related compounds.

Dr. Yi-Ren Hong received the PhD degree from University of Maryland at Baltimore (UMAB, USA) at 1993. In following, he started his post-doctor training at Veteran Hospital & UMAB for additional 1 year (1993 ~ 1994). He came back to Kaohsiung Medical University (KMU) and started to have a position as associated professor in Department Biochemistry at 1994. He has promoted as professor at 2001. Recently, Dr. Hong’s lab tries to establish a PKA-GSKIP-GSK3-Tau axis for Alzheimer's disease and also claims to propose PKA, GSK3 and BcL2L12 as promising therapeutic targets of brain tumors.

Codjo Hountondji is Distinguished Professor of Biochemistry and Molecular Biology at University Pierre et Marie Curie in Paris. He received his Master of Science in Enzymology (1978), a French Doctorate (equivalent to Ph.D.) (1981) and the French State Doctorate (Doctorat d’Etat Es-Sciences), the highest academic diploma (1985) from University of Orsay. At the University Pierre et Marie Curie, he has served as Chair of the Department of Biochemistry and Molecular Biology (2010-2014). He has been a Visiting Scientist at Penn State University School of Medecine in Philadelphia. Prof. Hountondji has authored 38 original research publications and patented one invention.

Dr. Jain earned his medical degree from Medical College, Rohtak in India. Dr Jain is internationally renowned in the fields of nuclear cardiology and molecular cardiovascular imaging; behavior, mental stress and heart disease; and cardiotoxicity of cancer chemotherapy. He has published over 130 original scientific papers, review articles and book chapters. He has served on the Board of Directors of the Cardiovascular Council of the Society of Nuclear Medicine (SNM) for over 10 years, the Education and Research Foundation (ERF) of the Society of Nuclear Medicine, the American Society of Nuclear Cardiology (ASNC).

Dr. Farrukh Jamal is Associate Professor of Biochemistry at Dr. Ram Manohar Lohia Avadh University, Faizabad, India. He has several years of teaching and research experience in the area of biochemistry which includes reproductive biochemistry, plant proteins & enzymes in waste water treatment and insect pest management of agriculturally important food crops. Dr. Jamal has several independent projects, participated in several seminars and conferences and published his work in internationally acclaimed books and journals. He has been bestowed with fellowship from CSIR, India.

Dr. Gary D. James is Professor of Anthropology, Nursing and Biomedical Engineering and Director of the Graduate Program in Biomedical Anthropology at Binghamton University. He has authored over 300 peer-reviewed publications and co-edited” Measuring Stress in Humans: A Practical Guide for the Field.” He is an elected fellow of the AAAS, the Society of Behavioral Medicine, an elected member of the Harvey Society, and a past-president of the Human Biology Association and American Dermatoglyphics Association.

Dr. Andras Kern has received his PhD in Biochemistry and Genetics in the Eotvos Lorand University in Budapest, Hungary. He has extensive research experience in neuropharmacology and new drug target identification and drug development in CNS disorders. His research focuses on studying dopamine signaling in CNS at the level of molecular, cellular and systems neuroscience to understand physiologically important behaviors such as memory and learning, stress-regulation, motivation and feeding behavioral. In particular, he interested in translating his findings to human nervous system diseases related in abnormal dopamine signal transduction. He has coauthored more than 30 scientific papers, abstracts, reviews and books chapter.

Dr. Kholmirzo T. Kholmurodov, is a Leading Scientist at Frank Laboratory of Neutron Physics, Joint Institute for Nuclear Research, Russian Federation. He has nearly 30 years of experience in field of molecular modeling for the physics, biochemistry and nanotechnologies. During his career at LIT JINR, Prof. Kholmurodov holds two scientific degrees, Candidate of Sciences (which is a PhD analog) and Doctor of Science - both in Physical- Mathematical sciences. Notably, Dr. Kholmurodov has authored more than 120 manuscripts, and edited several books of Japan-Russia International Workshops MSSMBS “Molecular Simulation Studies in the Material and Biological Sciences” as Organizing Chair.

Hideo Kimura graduated from the University of Tokyo in 1980 and received PhD degree in 1985. He served the National Defense Medical College (1980– 1990), Cancer Institute (1985- 1987), and Salk Institute for Biological Studies (1988-1999) where he discovered hydrogen sulfide (H2S) as a neuromodulator in the brain that he published in 1996. He became Director of the Department of Molecular Genetics, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo in 1999. He made discovery of another potential signaling molecule hydrogen polysulfide (H2Sn) in 2006. For his accomplishment, he received several awards including The Research Front Award from Thomson Reuter.

Dr Joanna Kopecka received her PhD degree from University of Turin, Italy in 2013. Her research focuses on basis of chemoresistance and immunoresistance of cancer cells. In particular, she is interested in finding new therapeutic approaches to target resistant cancer cells, using both pharmacological and molecular biology tools. She has coauthored more than 30 scientific papers, abstracts and reviews.

Adam Lesner, Professor of chemistry Faculty of Chemistry, University of Gdansk (UG), Head of the Analytical Biochemistry Laboratory. Ph.D. 2001, UG, D.Sc. 2009, UG, Research Associate (postdoc), Columbia University, New York, USA, 36 months.

Main research interest includes peptide and peptidomimetics and its synthesis and application in biological systems; chromogenic and fluorogenic peptides as substrates of proteolytic enzymes; protease activity based probes; reversible and irreversible inhibitors of such enzymes; anticancer peptides; antimicrobial peptides; cell penetrating peptides; combinatorial and parallel chemistry screening; biological assays based on protease activity; biomarkers detection. Author and co-author of 90 papers, 4 chapters in books and monographs, 2 patents, 2 patent applications, 80 short communications.

Dr. Aimin Liu is currently Professor and Lutcher Brown Distinguished Chair in Chemistry, Department of Chemistry, University of Texas San Antonio, USA. He did B.S. in Chemistry from the Department of Chemistry, University of Science and Technology of China in 1986. Later, he did Ph.D. in Biophysics, Department of Biochemistry and Biophysics, Arrhenius Laboratories for Natural Sciences, Stockholm University in 1999. Dr. Liu has numerous international scientific publications and honors to his credit.

Dr. Kenneth Maiese is an internationally recognized physician-scientist whose investigations are designed to translate basic science into successful therapeutic treatments. He maintains therapeutic and scientific expertise in multiple areas that include translational medicine, neurology, neuroscience, oncology, immunology, diabetes, psychiatry, cardiovascular disease, renal disease, biomarkers, and epigenetics. Dr. Maiese has received recognition with outstanding teaching awards and election to America's Top Physicians, and The Best of U.S. Physicians. Dr. Maiese holds several patents, has over 400 publications that include research papers, chapters, editorials and invited reviews, and has authored and edited multiple books.

PAOLO MAGNI received a degree in Medicine and a post-doctoral degree in Endocrinology at the Universita' degli Studi di Pavia (Italy) and a PhD degree in endocrinology and metabolism at the Universita' degli Studi di Milano (Italy). He is professor of pathology at the Universita' degli Studi di Milano (Italy).

His research domains include the molecular pathophysiology of metabolic diseases (obesity, diabetes, metabolic syndrome, dyslipidemia, atherosclerosis) and the nutritional/nutraceutical modulation of cardiometabolic risk, aging and health-related issues. He is conducting both experimental and clinical research. He is the author or co-author of over 85 scientific papers in peer-reviewed international journals.

Dr. Bramanandam Manavathi received his Ph.D. degree (2002) in Biochemistry from Sri Krishnadevaraya University, Anantapur, India. In 2007, Dr. Manavathi joined University of Hyderabad, India, where he is now working as an Associate Professor in the Department of Biochemistry. He is also a visiting scientist of The Terry Fox Laboratory, Vancouver, BC, Canada. He has been working in the field of cancer, specifically on breast cancer and ovarian cancer, for more than a decade and made significant contributions to the field. Dr. Manavathi, as an author/co-author, has published over 35 articles in various journals, having more than 1,125 total citations.

Dr. Rosa María Martínez-Espinosa (born February 1976) is a Spanish Senior Lecturer who is currently Vice-Dean of Postgraduate studies at the Faculty of Science (University of Alicante, Spain). Other positions she has held at the university include Vice-Dean of the Degree in Biology and Vice-Dean for Mobility and Enterprise, and Engagement, at the Faculty of Science (University of Alicante). Dr. Martínez-Espinosa completed her education at the University of Alicante (B.Sc. - Biology, Ph.D. - Biochemistry). Her research interests mainly involve archaea metabolism, enzymes purification and characterization, gene regulation, carotenoids production, waste water treatments, and brines bioremediation. She, as an author/co-author, has published more than 30 articles in various journals, having over 425 total citations.

Prof. Keiichi Matsubara obtained his degree in medicine in 1994 from Graduate School, Division of Medicine, Ehime University, Matsuyama, Japan. Prof. Matsubara currently works as an Assistant Professor in the Department of Obstetrics and Gynecology at Ehime University. His skills and expertise mainly lie in the subject areas of Prenatal Diagnosis, Fetal Growth Restriction, and Preeclampsia. Prof. Matsubara, as an author/co-author, has published more than 40 articles in various journals, having over 450 total citations.

Laurent Metzinger has completed Pharmaceutical studies and his PhD in Biological Sciences in Strasbourg, France and was a postdoctoral fellow from the University of Oxford (UK) in a leading lab on Duchenne muscular Dystrophy (Pr. Kay Davies). He works on microRNA regulation in INSERM-U1088 in Amiens, which focuses on vascular calcifications related on CKD. He has authored some of the first papers showing a role for microRNAs in CKD and published in reputed journals, including Nature and Cell. He teaches Biochemistry, Genetics and Molecular Biology in the Pharmacy School of Amiens.

Serena Montagnaro is Adjunct Professor at the Department of Veterinary Medicine and Animal Productions of the University of Naples Federico II. Her research interests include the study of mechanisms of cell death during viral infections and evaluation of performances of diagnostics tests in veterinary medicine. She is member of the Italian Association of Infectious diseases (ANIV) and participates in funded projects by Italian Ministry of Health.

Dr. Parang is Associate Dean of Research, Graduate Studies and Global Affairs and a Full Professor of Medicinal Chemistry and Pharmacology at Chapman University School of Pharmacy in Irvine, California. He received his Ph.D. in medicinal chemistry from the Faculty of Pharmacy at University of Alberta in 1997, followed by a postdoctoral study in the fields of carbohydrate chemistry and solid-phase organic synthesis in Department of Chemistry. He pursued additional postdoctoral studies at Rockefeller University in New York and Johns Hopkins University in Baltimore in bioorganic chemistry. He is an author of 170 peer-reviewed publications, 8 patents, and more than 140 meeting abstracts.

Roland Pieters completed his Ph.D. at MIT in 1995 and was an NWO Talent post-doctoral at the ETH-Zürich. He became an associate professor in 2005, obtained a VICI grant in 2008, and was promoted to full professor in 2010. His current research interests are directed towards glycodrugs, by studying the interference with protein-carbohydrate interactions using multivalent systems of varying architectures including those with rigid spacers, and using fragment libraries, for targets such as viral and bacterial adhesion proteins and toxins, galectins and glycosidases, Furthermore his group uses glyco- and peptide-microarrays in chemical biology and drug discovery e.g . on O-GlcNAcylation.

Dr. Pintus is Associate Professor of Biomedical Sciences at the Qatar University and Adjunct Associate Professor of Biochemistry and Head of the Laboratory of Cell Signaling and Redox Biology at the University of Sassari, Italy. He received his M.Sc. from the University of Sassari, and his Ph.D. from the University of Bologna. His postdoctoral training includes Biochemistry and Cell Biology. He spent three years at the Laboratory of Cardiovascular Science, NIA, NIH, Baltimore USA. Dr. Pintus authored more than 75 publications. His research interests include Oxidative stress, Cellular Redox State, Natural Antioxidants, Redox-regulated Signal Transduction and Vascular Biology.

Dr. Ajay Rana obtained his Ph.D. degree (1989) in Biochemistry from the Indian Institute of Chemical Biology, Calcutta, India. Dr. Rana is currently a Professor (Tenured) and Director of Research in the Department of Surgery at University of Illinois at Chicago, USA (since 2015). He is also Health Science Specialist at Jesse Brown VA Medical Center, Chicago, IL, USA (since 2016). He has a broad background in Cancer Biology, with specific training and expertise in signal transduction and anti-neoplastic drugs resistance. Dr. Rana, as an author/co-author, has published more than 65 articles in various journals, having over 2,150 total citations.

Dr. Angela Maria Rizzo is Associated Professor of Biochemistry at the Faculty of Pharmacy. Her research is devoted to the study of the functions of membrane lipids with particular reference to the microdomains in cell proliferation and signal transduction of cancer cells using biochemical and biophysical techniques. Moreover, her other research fields include: (a) the study of the role of omega-3 fatty acids in human nutrition in healthy subjects and (b) patients suffering from chronic degenerative diseases; the development of Functional Foods containing "Nutraceuticals" with antioxidant activity, Space Biology aimed at studying the effects of gravity and cosmic radiation on living organisms.

Dr. Schiller studied Chemistry and did his PhD in Biophysics investigating the degradation of polysaccharides by reactive oxygen species. Currently, he is group leader at Leipzig University. His research focus is on (phospho)lipids, their role in different pathologies and the investigation of lipid oxidation products generated under inflammatory conditions by using NMR, mass spectrometry and chromatographic techniques. He is particularly interested in combining the resolving power of thin-layer chromatography with the sensitivity of MS detection. He is the author of about 200 journal papers, reviews and contributions to books.

Dr. Shen is a Professor of Biology at College of Staten Island and a Professor of Biochemistry/Biology at the Graduate Center, City University of New York. He has more than 20 years of research experience and expertise in biochemistry, biotechnology, and molecular biology. His current research focuses on the mechanism of gene expression with the emphasis on the influence of epigenetic factors. Dr. Shen has received several research grants funded by NATO, NSF and NIH. Previously, Dr. Shen was a visiting scientist at National Institutes of Health in Bethesda, MD. Dr. Shen holds a Ph.D. in Biochemistry from University of Edinburgh, UK. He has authored more than 30 manuscripts and co-edited “Histones: Class, Structure and Function.

Dr. David E. Stec is Associate Professor of Physiology & Biophysics at the University of Mississippi Medical Center in Jackson, Mississippi. Dr. Stec holds a Ph.D. in Physiology from the Medical College of Wisconsin and did post-doctoral training in Genetics at the University of Iowa. His area of expertise is in the biochemistry and physiology of heme oxygenase and cytochrome P450 enzymes. Dr. Stec’s research has been funded by the National Institutes of Health and the American Heart Association. Dr. Stec has over 75 publications and is the author of the book “Heme oxygenase and the kidney.

Usman Sumo Friend Tambunan earned his Dr. degree in Chemistry from Tohoku University, Japan in 1986. Afterward, he carried out postdoctoral research at Kansas University, USA and in Taiwan. Prof. Tambunan research interests focus on drug and vaccine design using computational method for avian influenza, Ebola virus, dengue virus, and cervical cancer. His research includes the development of natural products, cyclic peptides, and fragment-based drug design to find a drug candidate to combat these diseases. For his research achievement and dedication, he has been rewarded with Satya Lencana in 2010 and 3rd Best Professor at Universitas Indonesia in 2009.

Dr. Luca Vanella is Associate Professor of Biochemistry at University of Catania (Italy). Dr. Vanella holds a Ph.D. in Pharmaceutical Science and He did his doctoral and post-doctoral training respectively at the New York Medical College (USA) and at the University of Toledo (USA). His area of expertise is in the biochemistry of heme oxygenase and arachidonic acid metabolism. Dr. Vanella’s research mainly focuses on the biochemical mechanism leading to insulin resistance and metabolic syndrome. Dr. Vanella has over 90 publications and He presently teaches biochemistry of nutrition at University of Catania.

Viktor Nedzvetsky obtained Ph.D. in biochemistry at Dnipropetrovsk University, Ukraine (1990). After postdoctoral training he received degree of Doctor Science at Kyiv National University (2006). Currently he is professor of Biophysics&Biochemistry dept. DNU where coordinates courses on Neurochemistry and Cancer Biochemistry. Since 2015 he is invited professor at Bingol University, Turkey as supervisor of PhD projects on genetic and molecular biology. His research interests are focused on cytoskeleton, astrocytes, cognitive deficits, bioactive compounds as anticancer agents, nanomaterials and neuroprotection. He is the author of over 190 research publications and 8 patents. He joins a journal “Regulatory Mechanisms of Biosystems”.

Dr. Václav Větvička is a Professor of Pathology and Director of Research in the Department of Pathology at the University of Louisville in Louisville, Kentucky, USA. He obtained his Ph.D. from the Czechoslovak Academy of Sciences. His postgraduate training included a stay at the Oklahoma Medical Research Foundation, Oklahoma City, OK, USA, and at the Institute of Microbiology, Prague, Czech Republic. His main area of research interest focuses on the development of natural immunomodulators. Dr. Větvička is an author/co-author of more than 200 peer-reviewed publications (having over 4,960 total citations), 8 books and 9 international patents.

Dr. Yamane is a guest researcher of Research Organization for University-Community Collaborations, Osaka Prefecture University. He has more than 20 years of experience in the biochemical and molecular biological fields. Previously, Dr. Yamane served as Lecturer at Hokkaido University in Sapporo, Japan. He has authored more than 30 papers.

Dr. Marcel Zámocký is principal investigator and senior scientist in research projects focused on the molecular evolution of defence against the oxidative stress. He published 63 publications in international peer-reviewed journals and was co-author of eight monographies. He was included among 2,000 Outstanding Scientist of the 21st Century accompanied with Citation of Meritorious Achievement issued by IBC Cambridge England UK and listed also in Marquis Who is Who in Science and Engineering for his achievements in molecular biology. He is contributor to PeroxiBase and molecular authority for catalase in Human Protein Reference Database. He is member of the Slovak Academy of Sciences, Bratislava, Slovakia.

Armando Zarrelli graduated in Chemistry at the “Federico II” University of Napoli in 1994. In 1998 he took his Ph.D. in Chemical Sciences and now he is a researcher in organic chemistry at the University of Naples. His current interests range from the study of pharmacological active molecules (including flavolignans derivatives, nucleoside analogues, synthetic oligonucleotides and glycomimetics) to the development of innovative methodologies in organic synthesis, as well as to the study of natural products used in the nutraceutical field.

Dr. Jie Zhang was born in 1980 in Shandong, China. He obtained his B.S. degree from Shandong University in 2003. Then he earned his Ph.D degree in medicinal chemistry from Shandong University in 2008. During his doctoral thesis, he had worked on the discovery of novel anticancer and anti-influenza agents through structural optimization of natural products. Thereafter, Dr. Jie Zhang joined Xi'an Jiaotong University and started his independent research activities in the area of medicinal chemistry. His current research focus is the identification and validation of novel molecular targets using photoaffinity labeling agents. Dr. Jie Zhang has published more than 70 SCI academic peer review papers.

Arash Zibaee is an assistant professor in department of plant protection, university of Guilan. His main study areas are digestive physiology and immunity of insects by emphasis on regulatory mechanisms to clarify whether they lead to suppressed population outbreaks of insect pests or increased efficacy of natural agents. He has more than 80 peer-reviewed papers in well-known journals. Moreover, he is a regular member of “Entomological Society of America” since 2011 and a member in “Awards and Honors Committee” for international Branch.

Dr. Zulfugarov obtained a doctorate (PhD) degree in Biophysics from Tbilisi State University, Georgia in 1988. After research experience at Institute of Botany, Azerbaijan National Academy of Sciences he moved to Pusan National University where presently works. He is also head of the Proteomics Lab at the Institute of Molecular Biology and Biotechnology, Azerbaijan National Academy of Sciences. Dr. Zulfugarov’s current research is focused on molecular biology, proteomics and metabolomics of plant response to environmental factors. Dr. Zulfugarov has authored more than 40 peer-reviewed manuscripts.

Dr. Atwood is a faculty member in the UW Division of Geriatrics and Gerontology and a Health Science Specialist in the Geriatric Research, Education and Clinical Center at the Madison VA Hospital. He received his PhD in Biochemistry from the University of Western Australia. The current focus of research in his laboratory relates to basic and clinical investigations into developing strategies to restore hormonal balance so as to halt the aging process. He has published over 200 scientific articles, is an inventor on eight issued U.S. patents, has served on numerous review boards, and is an editor of more than 50 scientific journals.

Dr. Frank Bordusa is currently working at Martin Luther University Halle-Wittenberg, Institute of Biochemistry, Department of Natural Product Biochemistry. He has authored more than 50 research articles/books. He is currently also serving as scientific Reviewer for various academic journals.

Oxana V. Galzitskaya is head of the Bioinformatics group at the Institute of Protein Research Russian Academy of Sciences. She graduated from the Moscow Physical-Technical Institute, Ph.D. in Biophysics (Institute of Theoretical and Experimental Biophysics, Pushchino, 1996), Doctor of Science (Institute of Theoretical and Experimental Biophysics, Pushchino, 2006). She is the author of 180 peer-reviewed publications. Area of expertise include protein physics, theoretical and experimental investigations of protein folding (investigation of protein folding and misfolding, prediction of protein disorder and structure prediction, prediction of amyloidogenic regions and folding rates), molecular biology, biochemistry, bioinformatics, search for factors triggering induction of amyloidosis in Alzheimer’s disease.

Dr. Christophe Hano obtained his Ph.D. (2005) in Plant Physiology and Molecular Genetics from University of Orléans, France. Since 2006, Dr. Hano is Associate Professor at University of Orleans with research activity at the Laboratoire de Biologie des Ligneux et des Grandes Cultures (EA1207, INRA USC1328), and Cosmactifs (CNRS GDR3711) Bioactifs et Cosmétique, on Lignan biosynthetic pathway regulation in flax (Linum usitatissimum L.). In terms of publications (scientific productions), he has published over 40 publications in international peer-reviewed journals, has published 2 book chapters, has given 85 presentations in international congresses and has over 500 citations.

Philip Harris is a full professor of School of Biological Sciences at University of Auckland. He received his Ph.D. University of Cambridge in 1971. Current research and clinical interests are in the composition, architecture, biosynthesis and degradation of plant cell walls in relation to dietary fiber in animal and human nutrition, cell wall evolution, especially of monocotyledons and wood quality. This research involves the use of microscopy as well as chemical and biochemical techniques. He has 125 articles in well reputed journals, 31 books, book chapters and edited books, 7 conference proceedings and 2 Patents published in his name.

Dr. Jedrzejas received his Ph.D. in Structural Chemistry from Cleveland State University/Cleveland Clinic Foundation in 1993. He was appointed an Assistant Professor of Microbiology at the University of Alabama at Birmingham in 1995. In 2001, Dr. Jedrzejas moved to the Children’s Hospital Oakland Research Institute as an Associate Scientist and then a Scientist. He currently directs a structural biology group at Children’s. His research interests include structural aspects of Gram-positive bacterial pathogens, mainly bacteria−host interactions, with focus on Streptococcus species, and mechanisms of essential processes leading to the formation of bacterial spores, their germination, and outgrowth, with an emphasis on Bacillus and Clostridium species.

Dr. Kotwal is an Adjunct Professor of Medicine at UMass Medical School. Dr. Kotwal received his Ph.D. in Biochemistry from McMaster University in Hamilton, Canada. He received his post doctoral training at the National Institutes of Health and he was a tenured Associate Professor at the University of Louisville when he took up the chair of Medical Virology at the University of Cape Town and was the recipient of the Senior International Wellcome Trust Fellowship for biomedical Sciences in South Africa. Dr. Kotwal has authored more than 100 pubmed listed manuscripts and is an inventor on many patents.

Dr. Samir Kumar Maji obtained his Ph.D. (2002) in Peptide Chemistry from the Department of Biological Chemistry, Indian Association for the Cultivation of Science (IACS), Kolkata, India. Dr. Maji is currently Associate Professor, since Sep 2014, in the Department of Biosciences and Bioengineering at IIT Bombay, Powai, Mumbai, where he is actually affiliated since Jan 2009. As an author/co-author, he has published more than 70 articles in various international journals with total citations more than 2,390. In 2015, Dr. Maji was awarded a 3-year membership at the American Chemical Society in recognition of engagement with the Society’s mission of service to the global community of chemists.

Dr. Annalisa Pastore obtained her Dottorato di Ricerca degree (equivalent to a Ph.D.) from the Laboratory of Spectroscopy, University of Naples, Italy, in 1986. Dr. Pastore is currently a Full Professor of the Department of Clinical Neurosciences at King's College London, UK. She was a post-doctoral fellow in the Department of Biochemistry at University of Oxford, UK (from 1986 to 1987). Her skills and expertise mainly lie in the subject areas of Structural Biology, Biophysics, Proteins, Biochemistry, Molecular Medicine, etc. Dr. Pastore, as an author/co-author, has published more than 275 articles in various journals, having a very significant number of total citations, i.e. over 10,650.

Dr. Manuel L. Penichet holds an M.D. and a Ph.D. degree in Biochemistry from the Havana Advanced Institute of Medical Sciences. He is currently working at University of California, Los Angeles (UCLA), USA, as Professor of Surgery and as Professor of Microbiology, Immunology & Molecular Genetics. He has published in prestigious medical journals, and has served as a consultant to the National Cancer Institute to implement a strategy to reduce the health disparities in cancer treatment (between minority populations and other ethnic groups in the USA). Dr. Penichet, as an author/co-author, has published more than 85 articles in various journals, having a significant number of total citations, i.e. over 2,705.

Dr. Alessandro Pini completed his Ph.D. in Biotechnology from the Molecular Biology Department, University of Siena, Italy. He is currently serving as an Associate Professor in the Department of Medical Biotechnology at the University of Siena. He is an author/co-author of dozens of scientific articles published in newspapers of biochemistry, biotechnology, oncology and microbiology, more than 90 communications at national and international conferences, and inventor of 9 international patents. He is the author of a textbook adopted for the teaching of Recombinant Antibodies in the Biotechnology Course at the University of Siena. He is founder and president of the biotech company SetLance srl.

Dr. Jan Potempa earned his Ph.D. and D.Sc. (habilitation) in Biochemistry in 1982 and 1993, respectively, from Jagiellonian University, Krakow, Poland. He is currently Research Professor and the Departmental Head of Microbiology at the Jagiellonian University (Faculty of Biochemistry, Biophysics and Biotechnology). His current scientific interest revolves around proteolytic enzymes of bacterial pathogens that play important roles in the deregulation of a number of physiological pathways and evasion of host immunity. Dr. Potempa’s research achievements (over 380 authored/co-authored papers) are highly recognized internationally, as indicated by more than 13,300 citations of his publications. For a decade, he was the second most cited scientist in Poland.

Dr. Olivier Renaudet completed his Ph.D. in Bioorganic chemistry from the University of Grenoble, France, in 2002. He is currently a Full Professor of Bioorganic chemistry at the University of Grenoble. Previously, he has been an Assistant Professor at University of Grenoble, and a Junior Member at the University Institute of France. His group is interested in Carbohydrate chemistry, peptide chemistry, chemical ligations, synthetic vaccines, and carbohydrate-protein interactions. Dr. Renaudet has published more than 90 papers in key international journals, including 9 book chapters, amounting to over 2,235 citations.

Dr. Boyd B. Scott obtained his Ph.D. degree (1988) in Immunology/Bacteriology from the Department of Bacteriology, University of Edinburgh, Edinburgh, UK. Dr. Scott is currently Director of Scientific Affairs at Merck Research Laboratories, North Wales, PA, USA. His skills and expertise mainly lie in the functional areas of Clinical Development, Clinical Pharmacology, Discovery, Medical Communications, Medical Affairs, Biostatistics, etc. Dr. Scott, as an author/co-author, has published more than 30 articles in various journals, having over 1,480 total citations.

Dr. Murat Şentürk is currently working in the Department of Chemistry at Ağrı İbrahim Çeçen University, Turkey. His skills and expertise mainly lie in the subject areas of Chromatography, Synthesis, Medicinal & Pharmaceutical Chemistry, Enzymes, Natural Product Chemistry, Enzyme Activity, Synthetic Medicinal Chemistry, Enzymology, Pharmaceutical Chemistry, Inhibition Studies, Carbonic Anhydrases, etc. Dr. Şentürk, as an author/co-author, has published more than 70 articles in various journals, having over 1,860 total citations.

Dr. Donna H. Wang obtained her M.D. degree in 1984 from Sun Yat-Sen University (School of Medicine), Guangzhou, China. Dr. Wang is currently Professor of Medicine and Chief of the Division of Nanomedicine and Molecular Intervention, in the Department of Medicine, at Michigan State University, East Lansing, MI, USA. Her research interests lie in the subject areas of cardiovascular pharmacology and physiology, hypertension, salt sensitivity, and hormonal and neuronal control of blood pressure. Dr. Wang, as an author/co-author, has published more than 125 articles in various journals, having a significant number of total citations, i.e. over 2,420.

Dr. Robert Clinton Webb is currently a Chairperson and Regents’ Professor in the Department of Physiology at Medical College of Georgia, Augusta, GA, USA. In addition, he is a Herbert Kupperman Chairperson of Cardiovascular Disease at Medical College of Georgia. His works mainly cover the following: the physiology of vascular smooth muscle; penile and clitoral erection in sexual dysfunction; cellular and subcellular mechanisms of contraction and relaxation of vascular smooth muscle; adrenergic neurotransmission in blood vessels; and, intercellular communication between vascular smooth muscle cells. Dr. Webb, as an author/co-author, has published more than 450 articles in various journals, having a very significant number of total citations, i.e. over 12,335.

Dr. Chaowu Xiao is currently working at Health Canada (Food Directorate), Ottawa, ON, Canada. Dr. Xiao’s skills and expertise mainly lie in the subject areas of Medicine, Biochemistry, Genetics, Molecular Biology, Agricultural and Biological Sciences, Nursing, Chemistry, etc. Dr. Xiao, as an author/co-author, has published more than 20 articles in various journals.

Dr. OS Adeyemi has obtained B.Sc. (Hons), M.Sc. and Ph.D. degrees in Biochemistry specializing in Medicinal Biochemistry, Toxicology and Neglected Tropical Diseases. He is a life scientist with several teaching and research experience in the university system. He is also an erudite scholar and a passionate academic mentor who accords significance to impacting lives through teaching, research and community service. He has published books, chapters in books as well as several research articles. He also reviews for and serves on the editorial board of several academic journals.

Arindam Basu obtained Ph.D. (Signal Transduction and Gene Expression) in 2006. Dr. Basu is currently serving as an Assistant Professor Penn State University, Brandywine Campus. Dr. Basu received Keystone Symposia Scholarship in 2008, and Best Poster award at the X FAOBMB Conference, Bangalore in 2003. Dr. Basu served as a course instructor for Biochemistry for 1st year veterinary students at University of Pennsylvania in 2014. He has contributed more than 10 publications.

Dr. Delitala is currently joining the Internal Medicine Unit at Azienda-Ospedaliero-Universitaria di Sassari as attending physician. His research focuses on the effect of subclinical thyroid diseases and their effect on the cardiovascular system. Other area of interest is autoimmune diabetes, in particular latent autoimmune diabetes in adults, and factors associated with insulin dependence.

Dr. Ko Chun Hay did B.Sc (Second-Up Class Honor) in Biochemistry and Ph.D. in Chinese Medicine from The Chinese University of Hong Kong in 2002 and 2006 respectively. Currently, he is working (a) as a Scientific Officer in Institute of Chinese Medicine, Science Centre East, Chinese University of Hong Kong, Shatin (b) as an Associate Manager in State Key Laboratory of Phytochemistry and Plant Resources in West China (c) as Scientific Manager, State Key Laboratory of Phytochemistry and Plant Resources in West China.

Dr. Adam de Lecq Le Gresley is an Associate Professor at School of Pharmacy and Chemistry, SEC Faculty, Kingston University. His professional qualifications include BSc (Honours) Chemistry from University of Surrey, Guildford and Doctor of Philosophy (PhD) in Synthetic Organic Chemistry from University of Surrey, Guildford. Dr. Gresley has numerous publications and honors to his credit.

Prof. Jihan Seid Hussein is a Professor in Medical Biochemistry Department, Medical Research Division, National Research Centre, Giza, Egypt. She is a Member of several international scientific societies, and was awarded a scientific encouragement prize in Biotechnology of the National Research Centre in 2011. She holds a Scientific Excellence Award for the research outputs of National Research Center for the years 2009, 2010, 2011, 2012, 2013 and 2014.

She has contributed in more than sixty international papers and fourteen international books. She is a Supervisor of many Master, PhD and MD theses, and is also a P.I. and member of many scientific projects. Furthermore, she is a Member in many international scientific societies, a Reviewer in more than twenty international journals, and has high experience in HPLC, Medicinal plant and induction of chronic diseases.

Dr. Kemal Türker Ulutaş earned his M.D. degree from Istanbul University (2007). He gained experience as Research Doctor in Andrology Laboratory of Center for Reproductive Medicine, Cleveland Clinic, USA. He is board-certified in Clinical Laboratory Leadership and Management by AACC, USA. His research area is centered on developing and integrating innovative medical diagnostic laboratory approaches to metabolic diseases. He has published novel original articles in high impact international journals. Currently, he is the director of Antakya State Hospital's Clinical Laboratories and Associate Administrator of the Hospital. He is owner and editor-in-chief of The ULUTAS Medical Journal.